Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 7/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MET | P08581 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4893048 | 0.94 | TSHR (0.42) | ATMSMN1; SMN2HCAR2TSHRADORA2A | |
| SCHEMBL540751 | 0.89 | ATM (0.47) | ATMSMN1; SMN2HCAR2TSHRALDH1A1 | |
| SCHEMBL440642 | 0.89 | ATM (0.47) | ATMSMN1; SMN2HCAR2TSHRALDH1A1 | |
| SCHEMBL4895739 | 0.86 | ALDH1A1 (0.39) | ATMSMN1; SMN2HCAR2TSHRALDH1A1 | |
| SCHEMBL3791086 | 0.83 | TSHR (0.50) | ATMHCAR2TSHRALDH1A1TP53 | |
| SCHEMBL3786038 | 0.83 | TSHR (0.50) | ATMHCAR2TSHRALDH1A1TP53 | |
| SCHEMBL3207425 | 0.83 | ATM (0.46) | ATMSMN1; SMN2HCAR2TSHRALDH1A1 | |
| SCHEMBL403340 | 0.83 | ATM (0.56) | ATMSMN1; SMN2HCAR2TSHRALDH1A1 | |
| SCHEMBL5974049 | 0.83 | ATM (0.56) | ATMSMN1; SMN2HCAR2TSHRALDH1A1 | |
| SCHEMBL2890674 | 0.83 | ATM (0.56) | ATMSMN1; SMN2HCAR2TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 818 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260112694-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES | Anthro Energy, Inc. (US) | 2026-04-23 | — | — | US | claimed |
| EP-4717744-A1 | USE OF A COMPOSITION BASED ON CYANOACRYLATE AND (METH)ACRYLATE | Bostik SA (FR) | 2026-04-01 | — | — | EP | claimed |
| US-20260088310-A1 | SHAPED BATTERY CELL AND METHOD OF MANUFACTURE | Anthro Energy, Inc. (US) | 2026-03-26 | — | — | US | claimed |
| US-20260041183-A1 | ADHESIVE FOR COSMETIC ARTICLE AND METHOD OF FORMING | FULLER H B CO (US) | 2026-02-12 | — | — | US | claimed |
| EP-4667546-A1 | PHOTOCURABLE COMPOSITION | Bostik SA (FR) | 2025-12-24 | — | — | EP | claimed |
| EP-4667545-A1 | PHOTOCURABLE COMPOSITION | Bostik SA (FR) | 2025-12-24 | — | — | EP | claimed |
| US-20250215132-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2025-07-03 | — | — | US | claimed |
| EP-3579890-B1 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES | FEMASYS INC (US) | 2025-06-18 | — | — | EP | claimed |
| WO-2025119862-A1 | COMPOSITION COMPRISING N-HEPTYLCYANOACRYLATE | BOSTIK SA (FR) | 2025-06-12 | — | — | WO | claimed |
| EP-4567084-A1 | COMPOSITION COMPRISING N-HEPTYLCYANOACRYLATE | Bostik SA (FR) | 2025-06-11 | — | — | EP | claimed |
| US-6512023-B1 | An adhesive composition includes a polymerizable adhesive monomer, at least one vapor phase stabilizer, and at least one liquid phase stabilizer. The combination of at least one vapor phase stabilizer and at least one liquid phase | CLOSURE MEDICAL CORPORATION | 2003-01-28 | — | — | US | claimed |
| WO-2003006236-A1 | COMPONENT OF PRINTED CIRCUIT BOARDS | GOULD ELECTRONICS INC. (US) | 2003-01-23 | — | — | WO | claimed |
| US-20030017357-A1 | Component of printed circuit boards | GOULD ELECTRONICS INC. | 2003-01-23 | — | — | US | claimed |
| WO-2001018068-A9 | RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS | LOCTITE CORP (US) | 2002-10-03 | — | — | WO | claimed |
| US-20020055573-A1 | Stabilized monomer adhesive compositions | CLOSURE MEDICAL CORPORATION (US) | 2002-05-09 | — | — | US | claimed |
| WO-2002020069-A2 | ANTIOXIDANT ENRICHED ADHESIVE COMPOSITIONS AND STORAGE CONTAINERS THEREFOR | CLOSURE MEDICAL CORPORATION (US) | 2002-03-14 | — | — | WO | claimed |
| WO-2002009784-A1 | ACRYLIC-BASED ADHESIVE COMPOSITION | UNIVERSIDAD DE ALICANTE (ES) | 2002-02-07 | — | — | WO | claimed |
| WO-2001018068-A1 | RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS | LOCTITE CORPORATION (US) | 2001-03-15 | — | — | WO | claimed |
| EP-0965623-A1 | Stabilized monomer adhesive compositions | Closure Medical Corporation (US) | 1999-12-22 | — | — | EP | claimed |
| US-5922783-A | METALLOCENE, PHOTOINITIATOR, CYANOACRYLATE COMPONENT; REDUCED BLOOMING, CRAZING | LOCTITE CORPORATION (US) | 1999-07-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260088310-A1 | SHAPED BATTERY CELL AND METHOD OF MANUFACTURE | FTO, DCX, TET1 | ATM 1912/4885SMN1; SMN2 3696/4885HCAR2 3507/4885 |
| US-20260041183-A1 | ADHESIVE FOR COSMETIC ARTICLE AND METHOD OF FORMING | KRT18, CDH1, CFL1 | ATM 2463/4885SMN1; SMN2 3903/4885HCAR2 3987/4885 |
| US-20260112694-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES | PARG, PUF60, PHOSPHO1 | ATM 614/4885SMN1; SMN2 528/4885HCAR2 3113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.